Marrow cell therapies for cardiovascular diseases
Christopher R Cogle1, Gerard J Madlambayan, Grant Hubsher
1Department of Medicine, Division of Hematology/Oncology, Program in Stem Cell Biology and Regenerative Medicine, University of Florida College of Medicine, Gainesville, FL 32610-0278, USA. c@ufl.edu
Regenerative medicine shows promise for cardiovascular disease, with early trials complete. Future research will optimize cell therapies for effective cardiac repair.
Area of Science:
- Regenerative medicine
- Cardiovascular disease research
Background:
- Preclinical data support marrow cells' hemangioblast potential and growth factors' cardioprotective effects.
- Numerous early-phase clinical trials have been conducted based on this preclinical evidence.
Purpose of the Study:
- To address remaining questions in cellular therapy for cardiovascular disease.
- To guide the next generation of studies for effective cardiac repair.
Main Methods:
- Focus on optimizing cell dose and type.
- Investigating optimal timing and route of administration.
- Exploring mechanisms of action and response measures.
Main Results:
- First wave of safety and efficacy trials are complete.
- Significant unknowns remain regarding optimal therapeutic parameters.
Conclusions:
- Further research is needed to refine cellular therapies for cardiovascular disease.
- Optimizing treatment parameters will pave the way for effective cardiac repair strategies.
More Related Videos
11:51Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Mesenchymal Stem Cells
Regulation of Hematopoietic Stem Cells
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Tissue Renewal without Stem Cells
However, failure of such a system...
